246 related articles for article (PubMed ID: 15864115)
21. Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure.
de Groote P; Helbecque N; Lamblin N; Hermant X; Mc Fadden E; Foucher-Hossein C; Amouyel P; Dallongeville J; Bauters C
Pharmacogenet Genomics; 2005 Mar; 15(3):137-42. PubMed ID: 15861037
[TBL] [Abstract][Full Text] [Related]
22. Beta-blocker pharmacogenetics in heart failure.
Shin J; Johnson JA
Heart Fail Rev; 2010 May; 15(3):187-96. PubMed ID: 18437562
[TBL] [Abstract][Full Text] [Related]
23. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Walsh R; Nelson P; Medway A; Davis G; Robertson AD; Port JD; Carr J; Murphy GA; Lazzeroni LC; Abraham WT; Liggett SB; Bristow MR
PLoS One; 2012; 7(10):e44324. PubMed ID: 23071495
[TBL] [Abstract][Full Text] [Related]
24. Long-term beta-blocker therapy improves diastolic function even without the therapeutic effect on systolic function in patients with reduced ejection fraction.
Tamaki S; Sakata Y; Mano T; Ohtani T; Takeda Y; Kamimura D; Omori Y; Yamamoto K
J Cardiol; 2010 Sep; 56(2):176-82. PubMed ID: 20493661
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population.
Mahesh Kumar KN; Ramu P; Rajan S; Shewade DG; Balachander J; Adithan C
J Cardiovasc Pharmacol; 2008 Nov; 52(5):459-66. PubMed ID: 19033826
[TBL] [Abstract][Full Text] [Related]
26. An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study.
White HL; de Boer RA; Maqbool A; Greenwood D; van Veldhuisen DJ; Cuthbert R; Ball SG; Hall AS; Balmforth AJ;
Eur J Heart Fail; 2003 Aug; 5(4):463-8. PubMed ID: 12921807
[TBL] [Abstract][Full Text] [Related]
27. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
[TBL] [Abstract][Full Text] [Related]
28. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.
Liggett SB; Mialet-Perez J; Thaneemit-Chen S; Weber SA; Greene SM; Hodne D; Nelson B; Morrison J; Domanski MJ; Wagoner LE; Abraham WT; Anderson JL; Carlquist JF; Krause-Steinrauf HJ; Lazzeroni LC; Port JD; Lavori PW; Bristow MR
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11288-93. PubMed ID: 16844790
[TBL] [Abstract][Full Text] [Related]
29. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure.
Groenning BA; Nilsson JC; Sondergaard L; Fritz-Hansen T; Larsson HB; Hildebrandt PR
J Am Coll Cardiol; 2000 Dec; 36(7):2072-80. PubMed ID: 11127443
[TBL] [Abstract][Full Text] [Related]
30. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.
Palazzuoli A; Bruni F; Puccetti L; Pastorelli M; Angori P; Pasqui AL; Auteri A
Eur J Heart Fail; 2002 Dec; 4(6):765-70. PubMed ID: 12453548
[TBL] [Abstract][Full Text] [Related]
31. Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction.
Horiuchi Y; Tanimoto S; Aoki J; Nakajima H; Hara K; Tanabe K
Int J Cardiol; 2016 Oct; 221():765-9. PubMed ID: 27428318
[TBL] [Abstract][Full Text] [Related]
32. Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension.
Karlsson J; Lind L; Hallberg P; Michaëlsson K; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Melhus H
Clin Cardiol; 2004 Jun; 27(6):347-50. PubMed ID: 15237695
[TBL] [Abstract][Full Text] [Related]
33. Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study.
Zoghi M; Kaya H; Çavuşoğlu Y; Aksakal E; Demir Ş; Yücel C; Mutlu H; Ergene O; Yılmaz MB;
Turk Kardiyol Dern Ars; 2016 Sep; 44(6):457-65. PubMed ID: 27665326
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).
Magvanjav O; McDonough CW; Gong Y; McClure LA; Talbert RL; Horenstein RB; Shuldiner AR; Benavente OR; Mitchell BD; Johnson JA;
Stroke; 2017 May; 48(5):1337-1343. PubMed ID: 28351962
[TBL] [Abstract][Full Text] [Related]
35. Cardiac reserve in the transplanted heart: effect of a graft polymorphism in the beta1-adrenoceptor.
Scharin Täng M; Lindberg E; Grüner Sveälv B; Magnusson Y; Andersson B
J Heart Lung Transplant; 2007 Sep; 26(9):915-20. PubMed ID: 17845930
[TBL] [Abstract][Full Text] [Related]
36. Neurohumoral prediction of left-ventricular morphologic response to beta-blockade with metoprolol in chronic left-ventricular systolic heart failure.
Groenning BA; Nilsson JC; Hildebrandt PR; Kjaer A; Fritz-Hansen T; Larsson HB; Sondergaard L
Eur J Heart Fail; 2002 Oct; 4(5):635-46. PubMed ID: 12413508
[TBL] [Abstract][Full Text] [Related]
37. Benefits of long-term beta-blockade in experimental chronic aortic regurgitation.
Plante E; Lachance D; Champetier S; Drolet MC; Roussel E; Arsenault M; Couet J
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1888-95. PubMed ID: 18296565
[TBL] [Abstract][Full Text] [Related]
38. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
[TBL] [Abstract][Full Text] [Related]
39. Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation.
Galves R; Da Costa A; Pierrard R; Bayard G; Guichard JB; Isaaz K
Echocardiography; 2020 Sep; 37(9):1392-1398. PubMed ID: 32815195
[TBL] [Abstract][Full Text] [Related]
40. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
